|Articles|November 6, 2013
- Pharmaceutical Commerce - November/December 2013
Commercial Data Sources for the Biopharma Industry
Advertisement
Click the link below to view the online, digital version:
Articles in this issue
about 12 years ago
Academics lay into drug coupon programs in NEJM:about 12 years ago
HDMA leadership remains with David Neu of AmerisourceBergenabout 12 years ago
FedEx, IAG Cargo unveil new cold-chain capabilitiesabout 12 years ago
A conversation with Michael Swanick, PwCabout 12 years ago
DME competitive bidding issues: When is enough enough?Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
The Great Repricing: How Pharma Must Evolve for Three Diverging Payer Economies
2
The ROI Moment Pharma Keeps Missing: Point-of-Care as Revenue Protection
3
Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies
4
Pharma Pulse: ACA Subsidy Gridlock Spurs Cost Crisis, as Lilly’s Retatrutide Delivers Positive Results in Phase III Trial
5
